AI assistant
Microbot Medical Inc. — Director's Dealing 2013
Jun 18, 2013
33819_dirs_2013-06-17_ad404017-82a9-44e1-90a3-e19d23c9e64a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-06-14
Reporting Person: MCGLYNN MARTIN M (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-06-14 | Common Stock | A | 700000 | $0.00 | Acquired | 1184664 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17317 | Indirect |
Footnotes
F1: Restricted stock units, with 1/4 vesting on June 14, 2014, 1/4 vesting on June 14, 2015, 1/4 vesting on June 14, 2016, and 1/4 vesting on June 14, 2017.
F2: Includes (1) 700,000 restricted stock units, with 175,000 of this vesting on each of June 14, 2014, June 14, 2015, June 14, 2016, and June 14, 2017; (2) 270,666 restricted stock units, with 135,333 of this vesting on each of January 27, 2014 and January 27, 2015, and (3) 40,000 restricted stock units vesting on June 25, 2013.
F3: Shares held in 401(k) account in accordance with issuer's employer-match policies.